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SUPPLEMENTARYDESCRIPTION
The project aimed to provide information that would enable a more complete assessment of
the risk associated with the use of live attenuated BluerorigLie virus vaccines in Australia
OBJECTIVES
(i) By May 1993, to achieve an efficacy level of at least 80% for the detection of vector
competence.
To deterTwine ifattenuated Bluetongue vaccine viruses will appear in the semen of
vaccinated rains.
(ii)
(in) By August 1993, to evaluate the vector competence ofC"Iicoides brevitarsis and C.
wadzi for Australian attenuated Bluerorigiie virus seed vaccine ofserotype 23.
By October 1994, to determine the vector competence of CMlicodies victoriae for
Australian BluerorigLie virus serotypes I and 21.
(iv)
METHODOLOGY
C"Iicoides brevitarsis and C. wadqi were caught at Utchee Creek Research Station using the
facilities established under Wool Research and Development Corporation (WRDC) project
DAQ. 4. Insects were transported to 00noonba, held for 24 hours then induced to feed on
viraerntc sheep and cattle. Engorged females were held for 8 - 10 days then exposed on a
susceptible animal to check for transmission. Allinsects were then killed. sorted into species
and processed for virus isolation.
Rains were vaccinated with the attenuated seed stock vaccine developed under project CS.
129. They were bled and ejaculated on days 4, 7, 10, 13 and 16 post vaccination and blood
and semen samples checked for presence of BluetongLie virus by PCR and inoculation into
susceptible sheep. Recipient sheep were held for 35 days to check for seroconversion.
Attenuated vaccine viruses were passaged through insects either during vector competence
trials or by direct inoculation of insects and through sheep or cattle. The virulence of progeny
viruses was compared to that of the parental vaccine virus and wild unmodified virus by
inoculation of susceptible sheep. Virulence was evaluated using the system developed at
00noonba underWRDC project DAQ. 4.
RESULTS
(i)
Three techniques, Polymerase chain reaction (PCR), minunospot test and virus isolation in
cell culture were compared for their efficiency in detecting virus in infected vectors.
PCR detected virus with 85% efficacy whereas jinmunospot test and isolation in cell culture
detected with elficacies of 42% and 10% respectively.
Wild caught C"Iicoides byevitorsis and C. wantzi were f^d on sheep vaccinated with the
attenuated Bluetongtie serotype 23 vaccine. Following a 10 day incubation period, virus was
Vector coin etence studies
detected and recovered from 0,9910 of 761 C. wadzi buttiom none of 501 C. brevitarsis that
had fed on the sheep.
(ii)
Two, 6 year old and 4, first season 3 year old rains were vaccinated with the attenuated seed
stock vaccine to Bluetongue serotype 23. Allrams were electroejacuated on days 4, 7, 10, 13,
and 16 post inoculation.
Excretion of virus in rain semen:
Bluerorigtie virus appeared in the semen of the 2 older rains on 2 occasions each. One rain
had virus in the semen on days 7 and 10 PI and the other on days 10 and 16 PI.
In the younger rains one had virus in the semen on day 4 PI, one on day 7 PI and a third was
suspect on day 7 PI and positive on day 13 PI. The fourth young rain was negative for virus
in semen on all occasions.
(in)
Attenuated Bluetongue virus serotype 23 was passaged through C. byevitorsis and cattle and
C. wod"I and sheep. The viruses recovered from the respective animals following the
passages were inoculated into 20 susceptible merino sheep. the sheep were monitored for 20
days for evidence of clinical signs of Bluerorigtie which would indicate reversion to virulence
Reversion to virulence:
None of the sheep developed any clinical signs of bluerorigue. A single sheep showed a
transient febrile response on day 8 but all other clinical parameters remained within normal
limits. All sheep developed strong antibody levels by day 14 post infection.
(iv)
Garlicoides victoriae and C. in"/rimoc"larus were collected in South Australia and Victoria,
transported to 00noonba and fed on sheep infected with Australian Bluerorigtie Serotype I. A
total of 445 C. victoriae and 500 C. inariiimoc"larus which had fed and survived the incubation
period were processed but no BluerorigLie virus was recovered indicating that neither insect is
a competent vector of bluerorigue viruses.
Vector coin etence ofC. victoriae
CONCLllSIONS
(i) Live attenuated Bluerorigiie serotype 23 vaccine was strongly antigenic and did not
revert to virulence following passage in CUIicoides spp. vectors and sheep or cattle.
(ii) The Australian vector C. wadqiwas able to be infected with the vaccine virus after
feeding on recently vaccinated sheep. There would be a high risk of the vaccine strain
being transnxitted in the field.
The vaccine virus appeared commonly in the semen ofvaccinated rains.(iii)
(iv) Gallicoides victoriQe and C. inariiimac"IQt"s are not competent vectors of Bluerorigue
virus and therefore, areas of Australia currently beyond the range ofC. brevitarsts can
be regarded as vector-free.
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BACKGROUNDANDIN'DUSTRYCONTEXT
Bluerorigiie virus was first identified from Australia in 1977, and since then 8 different
serotypes have been recognised in this country at one time or another. So far, two of these
serotypes (I and 21) have moved from the Northern Territory to the east coast of the
continent where they have come close to the commercial sheep raising areas, and continue to
be more orless active in cattle from year to year.
Pathogenicity studies with Australian bluerorigtie virus serotypes have shown several serotypes
capable of causing severe clinical disease and deaths in sheep. Recent vector competence and
virus distribution studies have independently indicated that Cuffcoides breviiorsis and C.
wadqi are the principal vectors of bluerorigtie virus in eastern Australia. The former has a
seasonal distribution that can extend wellinto sheep producing areas. Should virulent
serotypes cross into eastern Australia then the potential exists for outbreaks of severe clinical
disease in sheep.
All option for veterinary authorities to control an outbreak of disease is to vaccinate at-risk
sheep and possibly in contact cattle. Live attenuated viruses were prepared and evaluated
under project CS129 and although they appear efficacious they had undesirable side effects. A
disadvantage already demonstrated under that project was that modified viruses were
teratogenic. In ewes vaccinated in the first and second trimesters of pregnancy, up to 50% of
foetuses were lost and up to 13% of surviving foetuses were born with mild to severe
hydrancephaly and were non viable.
Prelinxinary results from Beminah suggest that passage of attenuated virus in cattle may result
in reversion to virulence. It was not known whether attenuated vaccine viruses would be
taken up by vectors, transmitted to other livestock and revert to virulence in the process.
Previous studies by CSll<O suggested that C. brevitorsis and C. woctzi had higher infection
rates with attenuated BTV20 than with urunodified virus.
Therefore 2 major risks may be associated with the use of live attenuated bluetongtie vaccines
ifthey are taken up by vectors. Firstly, the vaccine viruses may revert to virulence following
replication in the insect or during passage in cattle and thereby provide a reservoir of virulent
virus which could cause additional outbreaks of disease. Ifvaccination is undertaken in the
face of an outbreak then vaccinated animals are likely to be exposed to increased numbers of
competent vectors.
Secondly, even in the absence of a reversion to virulence the vaccine strains may persist in an
insect-host cycle and result in subsequent infections of pregnant animals. The potential losses
from foetal death and teratogenicity may be more costly to the local industry in the longer
term and outweigh the benefits gained from the control of a limited outbreak. To fully assess
the risks associated with the use of attenuated viruses it was necessary to know ifthe viruses
were genetically stable and ifexisting vectors could be infected with, and transmit, the viruses.
The coriumercial production and future storage of attenuated bluerorigiie vaccines will involve
industry and government in considerable expense. Industry must be aware of the risks before
a decision is made to comintt the substantial monies required to scale up to cornrriercial
vaccine production.
The recognised vectors in the east are C. brevitorsis and C. wadgi. Both species are not
usually found in the coriumercial sheep growing areas in numbers which might be expected to
initiate and sustain a disease outbreak in sheep, nor are they known to extend into Victoria or
South Australia. As yet there has been no serological evidence of bluerorigLie in that part of
the continent. However there is concern that in seasons favourable for C. byevit@rsis the
insect could expand its distribution and abundance to the point where it could take bluetongue
virusto areas where it has not occurred in the past. The virus may be picked up in those areas
by biting rindge species which feed on livestock and which have not been tested for bluerorigLie
virus vector competence. One of the most abundant of these is C. victoriae, which is found in
Victoria, South Australia, and also in Tasmania and the south-west of Western Australia. If
this species can act as a vector of bluerorigue it is possible that the virus could spread to these
areas where sheep are farmed. C. victoriae, unlike the known vectors C. 61evitarsis and C.
Trothi, does not breed in cow dung. If this species could act as a vector, it could take the
virus into areas where sheep are raised without the presence of cattle. There would be
potential disease problems and also difficulties with export of live animals from areas where
bluerorigLie virus was known to occur. Deternitnation of the vector competence of C.
victoriQe for bluerorigiie virus would enable assurances about the potential presence of
bluerorigue in these southern areas to be given to trading partners. Currently these trading
partners can justitiably question the vector status of the biting rindge species which they know
are found in the areas which are considered free of bluetongue.
OBJECTIVES
The objectives of the project changed during the course of the project. The objectives of the
original project which commenced on a 3 year cycle were related to the aim of the project as
contained in the supplementary description.
"This project aims to provide infonnation that will enable a more complete
assessment of the risk associated with the use of live attenuated Bluetongue virus
vaccines in Australia. "
The original objectives were as follows:
(i) By November 1993, to evaluate the virulence of attenuated Bluerorigue virus vaccine
for BTV23 foUowing passage in insects and cattle.
(ii) By February 1995, to determine fattenuated Bluerorigue vaccine viruses will appear in
the semen ofvaccinated rains.
(iii) By August 1995, to evaluate the vector competence ofC"11coides breviiarsis and C.
wooferI for Australian attenuated BluerorigLie virus vaccine strains.
(iv) By August 1995, to evaluate the virulence of attenuated Bluetongue virus vaccine for
BTV21 and BTVl following passage in insects and cattle.
By early 1993 prelinxinary results of the project supported by developments elsewhere in
Bluetongue research indicated that live attenuated bluetongue virus vaccines were unlikely to
be used in Australia. Therefore, the Corporation ternitnated the project under clause 27(a)(in)
of the agreement at the end of the first year.
The project was renegotiated to achieve dual aims. The first aim was to confirm the vector
competence of known Australian bluerorigue virus vectors for attenuated Bluerorigiie type 23
vaccine. The second aim was to provide virologicalsupport for AWRAPO project CT112 to
establish the vector competence of C. victoriae for Australian bluetongue virus serotypes.
The revised project wasto operate for I year only.
The revised objectives were as follows:
(i) By May 1993, to achieve an efficacy levelofat least 80% forthe detection of vector
competence.
(ii) By August 1993, to evaluate the vector competence of Cullcoides breviiarsis and C.
wadi for Australian attenuated Bluetongue virus (BTV) seed vaccine ofserotype 23
By October 1994, to deternitne the vector competence of Cullcoides victoriae for
Australian bluerorigue virus serotypes I and 21.
(in)
METHODOLOGY
(a) Vectorcompetence ofC, ,Iicoidesspp. for attenuated BLIJ23 vaccine
C. wadzi and C. brevitarsis were collected from wild populations at Utchee Ck Research
Station between February and June 1993. Collections of dung reared C. byevitarsis were
made from Bumside Stud (10km south of Ingham) in May and June 1994.
In 1993, insects were collected over penned cattle using the modified updraught light traps
developed in the recently completed WRDC project DAQ4. Several sites were available for
the collection of both vector species with the principal site being Utchee Creek Research
Station near Innisfail, Queensland. Collected insects were transported daily to the laboratory
in the high humidity cages developed under DAQ4. At the laboratory they were held for 24
hours, then exposed for feeding on viraenitc sheep vaccinated with attenuated BLU23. The
titre of virus in the blood of the animals was deternitned by piaque assay on Bin< cells.
Engorged females were held for 7 days, sorted to species then exposed to susceptible sheep to
check for virus transmission. All surviving insects were killed and processed for virus isolation
to deterThine vector infection rate. Insects were placed in liquid nitrogen until processing or
processed minediately. Insects were individually homogenised in sterile water to which tissue
culture medium was added. Part of each hornogenate was then pooled into groups of 10.
Each pool was inoculated onto B}11< cells for up to 4 passages. Positive pools were defined
by the presence of CPE.
(b)
Infection of insects with attenuated BTV23 was attempted 3 ways; by feeding on the ears of
sheep which had been inoculated 6-8 days previously, by intrathoracic inoculation, and by
capillary feeding on concentrated virus suspension. Regardless of route of attempted
infection, allinsects were held at 27"C for 7 days after feeding'inoculation. Throughout their
handling insects were fed only 10% sucrose. Following this incubation period the surviving
insect were killed, grouped into appropriate sized pools and ground and ajiquot's inoculated
into susceptible sheep or cattle. Viruses recovered from the inoculated animals were
subsequently inoculated into susceptible sheep to check for signs indicative of reversion to
virulence.
Reversion to virulence studies
(c)
Young and older rains were vaccinated with BLU23 vaccine and bled and electroejaculated on
days 4, 7, 10, 13 and 16 post vaccination. On each occasion, halfofeach semen sample was
inoculated into 2 susceptible sheep and the remainder was exanxined for presence of virus by
PCR. Each blood sample taken at the time of ejaculation was inoculated into a susceptible
sheep to confirm the presence ofviraemia.
(d) Vectorcompetencest"dieso" C victori"e
Collections of C. victoriae and the closely related C. in"/rimoc"lot"s were made in South
Australia and Victoria and the live insects were transported to Townsville. At the laboratory
they were fed on the ears of sheep infected with a field isolate of BLUl or fed through
artificial membranes on blood taken from sheep viraenxic with the field BLUl. Insects that fed
were held for 7 days at 25"C and then processed for virus isolation by serial passage in
embryonated chicken egg, insect cells (C636) and repeatedly in mammalian cellline (Bin<21).
Presence of attenuated BL1123 in rain semen
ACHmVEMENTOFOBJECTIVES
Original objectives
(i)
(ii)
(in)
(iv)
result achieved
result achieved
partial result achieved. Insufficient time to achieve complete result.
not attempted due to early termination of project
Revised objectives
(i)
(ii)
(iii)
result achieved
partial result obtained. Insufficient time to achieve complete result.
partial result obtained. No result was achieved for serotype 21 because no field isolate
ofBLU21 was available.
RESULTS
(i)
In 1993, a total of 846 C. wad7i and 76 C. brevitorsis were harvested after the 7 day
incubation period from a total of 2318 insects which fed on sheep. In 1994, a total of 461 C.
brevitarsis were harvested from a total of 805 insects that fed.
Vector competence ofC bre"jinrsis and C wad"ifor attenuated BLIJ23 vaccine.
C. wadqi: 85 pools were initially tested. However 12 of these pools were contarritnated
by fungi and could not be judged as positive or negative. The contaminated
pools were Tetested as pools of 5 insects to Thinintise the loss of data due to
fungi. 17 of these smaller pools were infected resulting in a total loss of 85
insects reducing the total number ofC. wadqireliably assessed to 761. These
The isolates were identified as BLU23 by virusyielded 7 isolates.
neutralisation assays. Assuming that each positive pool contained only I
infected insect this would yield a Thininxium infection rate for C. wadqi of 0.9%.
By comparison, an infection rate of 1.4% was calculated for wild BLU23 in C.
wadzi collected from the same location in 1989.
C. byevitarsis: In 1993, 8 pools were initially tested. I pool was subsequently retested as 2
pools of 5 resulting in 5 insects being lost to fungal contamination. This
reduced the total assessable number ofC. breviiarsis to 71. No isolates were
obtained from these insects. The pools were subsequently retested on a
different line of B}11< cells which appeared to be more sensitive to infection
than the previous line. However no isolates were obtained. In 1994, 46 pools
again, no isolates were obtained. Consequently thesewere tested. Once
results estimate that the infection rate of C. breviiarsis, with the attenuated
BLU23 is less than 0.19%. By comparison, an infection rate of 1.3% was
obtained with wild BLU23 in insects collected from Utchee Ck Research
Station in 1989. Other studies using different serotypes have found infection
rates as low as 0.04% onuller at a1 1992). The results of this study cannot
preclude the possibility of a similarly low infection rate for attenuated BLU23.
PCR techniques were developed for the diagnosis ofBLU presence in insects. The pools
reported above were tested in parallel in PCR. Approximately 90% of the pools were positive
indicating a much higher infection rate for both C. wad?I and C. brevitorsis than indicated by
the isolations. While the PCR is likely to be more sensitive to infections in insects it is also
possible that it detected remnants of viral RNA in the guts of urnnfected insects and thus
overestimated the infection rate.
Transnxission of the attenuated BLU 23 by the bite of infected insects was attempted once.
Transntission did not occur but was extremely unlikely as only I of the 100 C. wad"I exposed
to the sheep refed.
(ii)
(a) Passageofvaccinevirusininsects
(a. i) Capillary Feeding of Insects
45 insects were fed by glass capillary on a concentrated solution (7710gs TCr050/inI) of the
attenuated virus in tissue culture fluid to maxinxise the possibility of infection. Of these 2 C.
brevitorsis and 12 C. wadqisurvived the 7 day incubation and were processed as 3 pools, one
containing C. brevitorsis and the others containing 10 and 2 C. wad"irespectively. misolate
of virus was obtained from the pool containing 10 C. wad"i.
Reversion to virulence studies.
(aji)
Approximately 500 insects were inoculated with a concentrated virus solution (7.7 logs
Tcl050) of which 32 C. brevitorsis and 59 C. wadqisurvived the 7 day incubation. These
were mostly used in the development of the PCR and jinmunospot techniques. 7 C. wadqi
were tested for excretion of virus in the insects saliva by collecting saliva into a glass capillary
of sucrose solution and testing both the insects and the survose/saliva with PCR.
Several inoculated C. wadai were titrated in cells and the 2 which showed the highest titre
(calculated as 3.5 and 20 logs TCr050 for the whole insect) were selected for the reversion to
virulence trail.
Intrathoracic Inoculation
(b)
5 shorthorn cattle (approx 12 months old) were selected. The first was injected
subcutaneously (SC) with 0.5ml from a total of 2.5ml of hornogenate produced by crushing 10
untitrated inoculated C. wad7i. A weak seroconversion was obtained but no virus could be
isolated from any of the weekly blood collections made up to 35 days post-inoculation.
Virus passage in cattle and sheep
3 cattle each received SOLLI SC of the hornogenate (10 insects in 2.5ml) from a positive pool of
sheep-fed C. wad7i. Each received a different positive pool. However none seroconverted.
Consequently each was inoculated intravenously with a further 1501/1ftom the same pool as
the first inoculation. Again, however, none serconverted.
150Filftom each of the same pools was inoculated intravenously into 3 sheep (I pool per
sheep). Once again, none seroconveited.
The fifth bovine was inoculated subcutaneously with 50/11 of the hornogenate (from a total of
250Ftl) from the moonlated C. wadzi which had been titrated to 3.5 logs TCr050. However
the animal did not seroconvert. It was inoculated intravenously with a further 150LLl of the
same hornogenate and subsequently seroconverted. Blood (300ml per collection) was
collected weekly up to 35 days post-inoculation for testing in the pathogenicity trial against
sheep. Virus was recovered from this blood.
A fourth sheep was inoculated intravenously with 150Fil of the hornogenate of the titrated
inoculated C. wadgi which contained 20 logs TCr050. It subsequently seroconverted and
blood was collected weekly (300 rill per collection) for testing in the pathogenicaity trial
against sheep.
(c)
Each blood containing the viruses that had been passaged through insects-cattle and insect-
sheep was inoculated in 10 susceptible merino sheep. The animals were clinicalIy examined
daily for signs of bluerorigiie infection. One sheep (1131) inoculated with the insect-cattle
passaged virus showed a transient febrile response (Figure I) and none inoculated with insect-
sheep passaged virus showed a febrile response (Figure 2). No other clintcal signs of
bluetongue infection were seen in any of the sheep. All animals seroconverted confirming that
they had been infected with bluerorigiie virus (Table I).
Pathogenicity of passaged viruses for sheep
(in)
Two, 6 year old culled rains and 4, first season 3 year old rains were vaccinated with the
attenuated seed stock vaccine to Bluerorigtie serotype 23. All rams were electroejaculated on
days 4, 7, 10, 13 and 16 post inoculation (PI) and semen samples were examined for the
presence of bluetongLie virus by PCR and inoculation into susceptible sheep
Presence of attenuated bluetongue vaccine in ram semen
Bluerorigiie virus appeared in the semen of the 2 older rains on 2 occasions each. One rain
had virus in the semen on days 7 and 10 PI and the other on days 10 and 16 PI.
In the younger rains one was positive on day 4 PI, one on day 7 PI and a third was suspect on
day 7 PI and positive on day 13 PI. The fourth rain was negative for virus in semen on all
occasions. Results are shown in Table I. Virus was detected in semen only when rains were
viraermc.
Allsemen samples were exanxined forthe presence of blood and found to be free. The failure
of some of the recipient sheep from the younger rains to seroconvert suggests very low level
of virus in the semen.
Figure I. Temperature responses of 10 sheep inoculated with attenuated BLU23
passaged in Culicoides bra, jin, sis and cattle.
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Figure 2. Temperature responses of 10 sheep inoculated with attenuated BLU23
passaged in C"Iicoides wad"iand sheep.
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Table I.
Sheep
Group antibody levels of sheep inoc"lated with attenuated BLITZ3 that
had been passaged in insects and cattle or sheep.
1/31
1132
1133
1134
1135
1136
1137
1138
1139
1140
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Elisa
Titre
Sheep
99
63
95
96
75
61
72
91
84
92
1141
1142
1143
1144
1145
1146
1147
1148
1149
1150
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Elisa
Titre
88
102
93
97
84
93
93
87
83
1/2
Table 2
Rain 768
Day PI
4
Semen
Sheep
7
Appearance of attenuated BLU23 vaccine in the semen of rains following vaccination
10
PCR
13
Blood
16
+
980
+
Semen
+
+
ND
S
768, 980
1001, 1002, 1003, 1004
Sheep
+
+
+
ND
+
PCR
Not Done due to insufficient sample
Suspect
+
Blood
+
1001
+
Semen
+
Sheep
+
+
+
ND
PCR
+
+
Blood
+
6 year old rains
3 year old rains
1002
Semen
+
Sheep
+
+
PCR
+
+
Blood
1003
+
Semen
S
Sheep
+
+
PCR
+
+
Blood
+
1004
Semen
Sheep
+
+
+
PCR
+
Blood
+
+ +
+
+
+
(iv)
A total of 509 C. victoriae from Loxton S. A. and 10491 from Baimsdale, Vic. fed on viraentic
sheep. Feeding rates were higher in insects from Baimsdale. Post feeding survival rate (9%)
was sinxilar in insects from both locations. Only 45 C. victoriae from Loxton and 386 C.
victoriae and 558 C. in"trimoc"larus from Balmsdale were processed for virus isolation.
The population ofC. victorioe at Loxton was noticed to be atypical compared to populations
in eastern Australia. Females did not develop any abdontinal pigmentation during the
gonadotrophic cycle of blood digestion and egg maturation whereas the C. victoriae from the
Baimsdale population did develop some pigmentation as expected with C. victoriae. This
suggests variation within the species and illustrates the value of collecting C. victoriae from
more than I site in order to produce a reliable assessment of its potential as a vector.
Vector competence ofC"Iicoides victori"e
No virus was recovered from any of the insects.
By combining the Loxton and Bannsdale insects these results estimate that for BLU I, C.
victoriae and C. in"Inmac"/at"s have infection rates of less than 0.2%. For C. breviiorsis,
infection rates as low as 0.44% have been recorded for other bluetongtie isolates.
Consequently these results cannot definitively preclude the possibility of a sinxilarly very low
infection rate occurring in either C. victoriae or C. in"/itmac"/dins. To do so would require
processing of many more insects.
(v)
No intellestual property resulted from or arose in the course of carrying out the project.
Intellectual Property
(vi) Recommendations for commercial exploitation of results
The results indicate that use of live attenuated bluerorigLie vaccines would pose considerable
risks for the Australian livestock industries and therefore commercial production of such
vaccines cannot be recommended.
(vii)
Total corporation funds expended on the project were $259,269.
Total funding and MRC contribution
(viii) Impact on Meat and Livestock Industry
The cessation of development of attenuated bluetongue vaccines means that the Australian
livestock Industry has no vaccine available for use in the event of an outbreak of clinical
bluetongue. There is no impact on the livestock industry ifthere is no outbreak of clinical
disease. Alternative vaccine options could be progressed in the next 5 years.
The confirmation of C. victorioe and C. multimact, I@t"s as non competent vectors of
bluerorigue viruses should enable Australia to more confidently negotiate bluetongue - free
status for livestock producing areas beyond the range of C. brevitarsis. This should allow
greater market access for live ruminants and runtinant genetic material from these areas.
